Superficial Inguinal and Radical Ilioinguinal Lymph Node Dissection in Patients with Palpable Melanoma Metastases to the Groin - An Analysis of Survival and Local Recurrence

References

• Finck SJ, Giuliano AE, Mann BD, Morton DL. Results of ilioinguinal dissection for stage II melanoma. Ann Surg 1982; 179: 156–9.
   Google Scholar
• Karakousis CP, Driscoll DL. Groin dissection in malignant melanoma. Br J Surg 1994; 81: 1771–4.
   PubMed Web of Science ®Google Scholar
• Kissin MW, Simpson DA, Easton D, White H, Westbury G. Prognostic factors related to survival and groin recurrence following therapeutic lymph node dissection for lower limb malignant melanoma. Br J Surg 1987; 74: 1023–6.
   Google Scholar
• Singletary SE, Shallenberger R, Guinee VF. Surgical manage-ment of groin nodal metastases from primary melanoma of the lower extremity. Surg Gynecol Obst 1992; 174: 195–200.
   Google Scholar
• Sterne GD, Murray DS, Grimlley RP. Ilioinguinal block dissection for malignant melanoma. Br J Surg 1995; 82: 1057 —9.
   Google Scholar
• McCarthy JG, Haagenson CD, Herter FP. The role of groin dissection in the management of melanoma of the lower extremity. Ann Surg 1974; 179: 156–9.
   Google Scholar
• Mann GB, Coit DG. Does the extent of operation influence the prognosis in patients with melanoma metastatic to the inguinal nodes. Ann Surg Oncol 1999; 6: 263–71.
   PubMed Web of Science ®Google Scholar
• Strobbe LJA, Jonk A, Hart AAM, Nieweg OE, Kroon BBR. Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol 1999; 6: 255–62.
   Google Scholar
• Coit DG, Brennan MF. Extent of lymph node dissection in melanoma of the trunk or lower extremity. Arch Surg 1989; 124: 162–6.
   PubMedGoogle Scholar
• Zoltie N, Chapman P, Joss G. Is iliac node clearance neces-sary for stage II melanoma? Plast Reconstr Surg 1991; 88: 810–3.
   PubMed Web of Science ®Google Scholar
• Jonk A, Kroon BBR, Rilmke P, van der Esch EP, Hart AAM. Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both. Surg Gynecol Obstet 1988; 28: 28–32.
   Google Scholar
• Karakousis CP, Driscoll DL. Positive deep nodes in the groin and survival in malignant melanoma. Am J Surg 1996; 171: 421–2.
   PubMed Web of Science ®Google Scholar
• Karakousis CP, Lawrence JE, Uma R. Groin dissection in malignant melanoma. Am. J. Surg 1986; 152: 491–5.
   Google Scholar
• Karakousis CP, Emrich LJ, Driscoll DL, Rao U. Survival after groin dissection for malignant melanoma. Surgery 1991; 109: 119–26.
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Meier P. Nonparametric estimation from incom-plete observations. J Am Stat Assoc 1958; 53: 457–86.
   Web of Science ®Google Scholar
• Cox DR. Regression model and life tables. J Royal Stat Soc 1972; 34: 187–220.
   Google Scholar
• Calabro A, Singletary E, Balch CM. Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases. Arch Surg 1989; 124: 11051–5.
   Google Scholar
• Roses DF, Provet JA, Harris NM, Gumport SL, Dubin N. Prognosis of patients with pathologic stage II malignant melanoma. Arch Surg 1985; 201: 103–7.
   Google Scholar
• Cascinelli N, Vaglini M, Nava M, et al. Prognosis of skin melanoma with regional node metastases (Stage 11). J Surg Oncol 1984; 25: 240–7.
   PubMed Web of Science ®Google Scholar
• Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Ann Surg 1991; 214: 491–501.
   Google Scholar
• Fortner JG, Booher JR, Pack GT. Results of groin dissection for malignant melanoma in 220 patients. Surgery 1964; 55: 485–8.
   Google Scholar
• Dasmahapatra KS, Karakousis CP. Therapeutic groin dissection in melanoma Surg Gynecol Obstet 1983; 156: 21–4.
   PubMed Web of Science ®Google Scholar
• Shaw IHF, Rumball EM. Complications and local recurrence following lymphadenectomy. Br J Surg 1990; 77: 760–4.
   PubMed Web of Science ®Google Scholar
• Monsour PD, Sause WT, Avent JM, Noyes RD. Local con-trol following therapeutic nodal dissection for melanoma. J Surg Oncol 1993; 54: 18–22.
   PubMed Web of Science ®Google Scholar
• Lee RJ, Gibbs JF, Proubc GM, Kollmorgen DR, Jia C, Kraybill WG. Nodal basin recurrence following lymph node dissection for melanoma: implications for adju-vant radiotherapy. Int J. Radiat Oncol Biol Phys 2000; 46: 467–74.
   PubMed Web of Science ®Google Scholar
• Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1–39.
   PubMed Web of Science ®Google Scholar
• Kretschmer L, Lautenschläger C, PreuBer K-P, Fiedler H. Groin recurrence following therapeutic lymph-node dissection in malignant melanoma Langenbecks Arch Surg 1993; 378: 211–6.
   Google Scholar